Genome-Wide Analysis of Pain-, Nerve- and Neurotrophin -Related Gene Expression in the Degenerating Human Annulus by Helen E Gruber et al.
MOLECULAR PAIN
Gruber et al. Molecular Pain 2012, 8:63
http://www.molecularpain.com/content/8/1/63RESEARCH Open AccessGenome-wide analysis of pain-, nerve- and
neurotrophin -related gene expression in
the degenerating human annulus
Helen E Gruber1,2*, Gretchen L Hoelscher1, Jane A Ingram1 and Edward N Hanley Jr1Abstract
Background: In spite of its high clinical relevance, the relationship between disc degeneration and low back pain
is still not well understood. Recent studies have shown that genome-wide gene expression studies utilizing
ontology searches provide an efficient and valuable methodology for identification of clinically relevant genes.
Here we use this approach in analysis of pain-, nerve-, and neurotrophin-related gene expression patterns in
specimens of human disc tissue. Control, non-herniated clinical, and herniated clinical specimens of human
annulus tissue were studied following Institutional Review Board approval.
Results: Analyses were performed on more generated (Thompson grade IV and V) discs vs. less degenerated discs
(grades I-III), on surgically operated discs vs. control discs, and on herniated vs. control discs. Analyses of more
degenerated vs. less degenerated discs identified significant upregulation of well-recognized pain-related genes
(bradykinin receptor B1, calcitonin gene-related peptide and catechol-0-methyltransferase). Nerve growth factor
was significantly upregulated in surgical vs. control and in herniated vs. control discs. All three analyses also found
significant changes in numerous proinflammatory cytokine- and chemokine-related genes. Nerve, neurotrophin
and pain-ontology searches identified many matrix, signaling and functional genes which have known importance
in the disc. Immunohistochemistry was utilized to confirm the presence of calcitonin gene-related peptide,
catechol-0-methyltransferase and bradykinin receptor B1 at the protein level in the human annulus.
Conclusions: Findings point to the utility of microarray analyses in identification of pain-, neurotrophin and
nerve-related genes in the disc, and point to the importance of future work exploring functional interactions
between nerve and disc cells in vitro and in vivo. Nerve, pain and neurotrophin ontology searches identified
numerous changes in proinflammatory cytokines and chemokines which also have significant relevance to disc
biology. Since the degenerating human disc is primarily an avascular tissue site into which disc cells have
contributed high levels of proinflammatory cytokines, these substances are not cleared from the tissue and
remain there over time. We hypothesize that as nerves grow into the human annulus, they encounter a
proinflammatory cytokine-rich milieu which may sensitize nociceptors and exacerbate pain production.
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Low back pain brings the patient to the spine surgeon,
but the relationship between disc degeneration and pain
production in the disc is still poorly understood. Patients
with chronic low back pain do not have the leg pain
which results when fragments of herniated disc push on
nerves; instead, these patients experience pain that is
thought to arise from the disc itself. Although some back
pain may be related to lumbosacral anatomy/function
spinal anatomy [1], age, and other factors (see Fairbank
et al. for a recent systematic review of low back pain
classification [2]), discogenic low back pain is not well
understood [3-8]. As with all pain, the pain-initiating
event results from complex cellular, molecular and func-
tional events at the nociceptors (naked nerve endings)
[9,10]. Discogenic pain is believed to result from disc
changes (possibly from outer annulus pressure on nerve
endings, disc cell dysfunction, products of matrix deg-
radation [11], or unknown events) which influence the
nervous system by stimulation of annulus nociceptors.
Recent studies focused over the last decade on mo-
lecular events and gene expression patterns related to
pain [12], and studies have revealed that genome-wide
gene expression studies provide a powerful methodology
for identification of clinically relevant genes [13]. The
objective of the present study was to perform a genome-
wide analysis of annulus tissue from patients with disco-
genic back pain, compared to disc tissue from control
subjects and herniated disc patients, in an analysis of the
expression of pain, nerve and neurotrophin-related
genes. Ontology searches for these specific topics were
utilized in order to avoid searching large gene array data
bases gene by gene, and because this technique provides
a controlled vocabulary of search terms for gene charac-
teristics [14].
As cell-based therapies for disc degeneration progress,
information on pain-, nerve- and neurotrophin-gene
expression in disc tissue becomes increasingly import-
ant. Findings presented here have potential applications
in future treatment modalities, such as perispinal admin-
istration of TNF-α inhibitors (such as etanercept/enbrel
[15]) or use of specific small molecular antagonists to
neurotrophins. New information presented here on the
relationship between proinflammatory mediators, nerves
and neurotrophins has the potential to contribute to
future important antagonist profiles with application to
discogenic back pain.
Results
Demographic features of the patient population are
summarized in Table 1 which presents spinal site, grade,
subject age, and whether surgical specimens were
derived from herniated or non-herniated tissue. In the
present work, gene expression analyses included threeThompson grade II and five grade III control disc speci-
mens (obtained from Cooperative Human Tissue Net-
work). Surgical specimens were analyzed from three
grade II discs (two specimens of which were from her-
niated discs), four grade III discs (from herniated discs),
five grade IV specimens (two of which were from her-
niated discs), and three grade V specimens (two of which
were from herniated discs).
The ontology gene expression analysis for pain and
nerve categories included a variety of biological pro-
cesses, molecular functions, and cellular components.
To assist the reader in understanding these, Table 2
outlines the categories included in our searches.
In each of our summary tables on gene expression
findings (Tables 3, 4 and 5), genes are listed which have
relevance to nerves, pain and neurotrophins (listed in
section A of Tables 3, 4 and 5), genes with relevance to
proinflammatory cytokines and chemokines (listed in
section B of Tables 3, 4 and 5) and genes with specificity
not only to nerve, pain and neurotrophins but also to
the disc itself (listed in section C of the tables).
Neurotrophin-, nerve-, and pain-related gene, and disc
gene expression patterns in the annulus: expression
patterns in more degenerate compared to less
degenerate discs
In Table 3, findings are presented for selected relevant
genes which were significantly elevated in expression
in more degenerated Thompson grade IV and V discs
compared to findings in grades I, II and III discs.
Of major interest in Table 3 are a number of genes
with high relevance to pain, neurotrophins and nerves.
These include significantly upregulated expression in
the more degenerated discs of the following: bradykinin
receptor B1, calcitonin gene-related peptide, catechol-O-
methyltransferase, neuron navigator-1 and −2, neuropi-
lin 2, and reticulon 4 (also known as neurite growth
inhibitor). These genes showed up regulation fold
changes ranging from 1.09 to 4.61.
A large number of genes in the ion transport grouping
showed significant changes in this analysis; 69 genes
showed significant up regulation, and 59 significant
down regulation (most data not shown).
Genes with specific high relationships to disc cell
biology included these significantly upregulated genes in
the more degenerated discs: apoptosis-inducing factor
(mitochondrion associated), BMP receptor, type II, col-
lagens type I, III, IV, V and VI, connective tissue growth
factor, fibronectin, hypoxia inducible factor 1 (HIF1),
several of the mitogen-activated protein kinases, SPARC
(osteonectin), TGF-ß, lumican and TIMP metallopepti-
dase inhibitors-2 and −3. These genes showed upregula-
tion fold changes ranging from 1.42 to 17.58. Nitric
oxide synthase 3 showed a 4.77 fold downregulation.
Table 1 Demographic data on disc tissues*
Subject number Site* Thompson grade Age (years)/gender Herniated? Other information
1 Lumbar II 34/F No Control
2 L3-L4 II 30/M No Control
3 L4-L5 II 54/F No Surgical specimen
4 Lumbar II 34/F No Control
5 L5-S1 II 21/M Yes Surgical specimen; immuno **
6 L4-L5 II 40/F Yes Surgical specimen
7 L4-L5 III 36/F Yes Surgical specimen
8 C6-C7 III 45/F Yes Surgical specimen
9 L3-L4 III 52/F No Control
10 L3-L4 III 52/F No Control; immuno
11 L3-L4 III 52/F No Control
12 L3-L4 III 52/F No Control
13 L2-L3 III 33/F No Control
14 L5-S1 III 37/M Yes Surgical specimen; immuno
15 L4-L5 III 43/M Yes Surgical specimen; immuno
16 L5-S1 IV 63 F No Surgical specimen
17 L2-L3 IV 65/F No Surgical specimen
18 C5-C6 IV 59/M Yes Surgical specimen
19 L5-S1 IV 45/M Yes Surgical specimen; immuno
20 L5-S1 IV 43/M No Surgical specimen
21 L5-S1 V 72/F Yes Surgical specimen; immuno
22 L4-5 V 41/M No Surgical specimen; immuno
23 C6-7 V 57/F Yes Surgical specimen
* Note that multiples specimens may have been derived from some subjects. L, lumbar; C, cervical; M, male; F, female; Control discs are normal discs obtained
from the Cooperative Human Tissue Network.
** Indicates that specimens were utilized for selected immunohistochemical studies.
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gene expression patterns in the annulus: analysis of
expression patterns in surgical compared to control
(CHTN) specimens
In Table 4, findings are presented for relevant genes
which were significantly upregulated in surgically oper-
ated disc specimens compared to expression findings in
control (CHTN) discs.
Of high interest in Table 4 are a number of genes with
high relevance to pain, neurotrophins and nerves. These
include the following: calcitonin gene-related peptide,
catechol-O-methyltransferase, ciliary neurotrophic fac-
tor, nerve growth factor, neuron navigator 1, neuropilin
2, reticulon 4, and roundabout axon guidance receptor.
These genes showed up regulation fold changes ranging
from 1.2 to 5.96.
A large number of genes in the ion transport grouping
also showed significant changes in this analysis; 87 genes
showed significant up regulation, and 73 significant
down regulation (most of the gene data in the ion trans-
port group are not shown here).
Genes with specific high relationships to disc cell biol-
ogy included these significantly upregulated genes insurgical vs. control discs: heat shock proteins, fibronectin
1, versican, lumican, several of the mitogen-activated pro-
tein kinases, TIMP metallopeptidase inhibitors-3 and −4,
TFG-ß, latent TGF binding protein 1, several of the TNF
receptors, and collagen type II alpha 1. These genes
showed up regulation fold changes ranging from 1.1 to
66.35. Notable down regulated genes included brevican
and FGF 5 (with fold changes of 1.3 and 1.4, respectively).
Neurotrophin-, nerve-, and pain-related gene, and disc
gene expression patterns in the annulus: expression
patterns in herniated compared to Non-herniated discs
Although not related to discogenic low back pain, we
were also interested in evaluating our data in terms of
expression patterns which were significantly different in
herniated discs vs. non-herniated discs (Table 5).
Of high interest in Table 5 are a number of genes with
high relevance to pain, neurotrophins and nerves. These
include the following: Calcitonin gene related peptide
(down regulated 1.2 fold). Upregulated genes included
neuropilin 2, nerve growth factor, reticulon 4, round-
about axon guidance receptor; these genes were upregu-
lated 1.5 to 5.58 fold.




a. Sensory perception of pain:
I. Regulation of sensory perception of pain
II. Detection of chemical stimulus involved
III. Detection of temperature stimulus involved




5. Response to pain:
a. Behavioral response to pain
6. G-protein coupled receptor (protein) signaling pathway
7. Transmission of nerve impulse
8. Fatty acid catabolic process
B. Molecular Function:
1. 1. Carboxyl- or carbamoyl-transferase activity
2. Opioid peptide activity
3. Signal transducer activity
a. G-protein coupled receptor activity
b. Galanin receptor activity
c. Bradykinin receptor activity
d. Opioid receptor activity
e. Adrenergic receptor activity
4. Voltage-gated channel activity
5. G-protein coupled receptor binding
C. Cellular component






i. Positive regulation of neuron apoptosis
ii. Negative regulation of neuron apoptosis
a. Neurotrophin production
iii. Neuroprotection
2. Neuropeptide signaling pathway
3. Transmission of nerve impulse
4. Nervous system development:
a. Nerve development
b. Neurogenesis
i. Regulation of neurogenesis
a. Positive regulation of neurogenesis
Table 2 Outline of ontology search strategies (Continued)
b. Negative regulation of neurogenesis
ii. Neuron differentiation
a. Neuron projection development
i. Axonogenesis regulation:
a. Positive regulation of axonogenesis






a. Nerve growth factor binding
2. Neurotrophin receptor activity
3. Neurotransmitter receptor activity
a. Substance P receptor activity
4. Calcitonin receptor binding
5. Vascular endothelial growth factor (-activated) receptor activity
6. Protein kinase activity
7. Neuropeptide hormone activity
8. Neuropeptide binding
9. Ciliary neurotrophic factor receptor binding
10. Neurotrophin receptor binding:





2. Endoplasmic reticulum lumen
3. Nuclear outer membrane
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also showed significant changes in this analysis; 98 genes
showed significant up regulation, and 39 significant
down regulation (most data not shown).
Genes with specific high relationships to disc cell biol-
ogy included these significantly upregulated genes: a
number of the collagens, fibronectin 1, hypoxia inducible
factors-1 and −2 (alpha subunit), latent TGF-ß binding
protein 1, TGF-ß receptor 1, several of the mitogen-
activated protein kinases, proteoglycan 4, SOD , and the
apoptosis-associated genes caspase 6 and TNFRSF1A-
associated via death domain.
Immunohistochemical studies
Paraffin-embedded annulus tissue was available for sev-
eral of the subjects studied here (subjects # 5, 10, 14, 15,
19, 21 and 22 (Table 1) which enabled us to perform
immunolocalization studies for products of three of the
Table 3 Significant differences in pain-, neurotrophin-, nerve-, and disc-related genes in more degenerated discs
(Grades iv and v) compared to less degenerated discs (Grades i – iii)
Gene name Gene identifier Fold change Direction p-value
A. Pain-, Neurotrophin- and Nerve-related Genes
Adrenergic, beta, receptor kinase 2 AI478542 1.16 Up 0.045
Ataxin 10 AF119662 2.62 Up 0.008
Bradykinin receptor B1 NM_000710 1.09 Up 0.023
Calcitonin gene related peptide AI478743 1.51 Up 0.035
Catechol-O-methyltransferase NM_001670 1.17 Up 0.020
Cholinergic receptor, muscarinic 1 AI500293 1.60 Down 0.042
Clusterin M25915 12.76 Up 0.010
EGF, latrophilin and seven transmembrane domain containing 1 NM_022159 1.74 Up 0.040
Endoplasmic reticulum aminopeptidase 2 BE889628 1.28 Up 0.036
Endoplasmic reticulum protein 44 BC005374 2.08 Up 0.043
GABA binding protein 2 BC002557 4.54 Down 0.027
GABA(A) receptor-associated protein NM_007278 3.78 Up 0.049
Gap junction protein, alpha 1, 43 kDa NM_000165 4.91 Up 0.017
Glutathione peroxidase 1 NM_000581 3.42 Up 0.036
Glutamate receptor, metabotropic 1 U31216 1.06 Up 0.0082
Guanine nucleotide binding protein (G protein), gamma 10 NM_004125 2.97 Up 0.049
Guanine nucleotide binding protein (G protein) alpha inhibiting activity
polypeptide 3
J03198 3.22 Up 0.021
Guanine nucleotide binding protein (G protein) beta polypeptide 1 NM_002074 4.04 Up 0.015
Heat shock protein 90 kDa alpha (cytosolic), blass B member 1 AF275719 2.96 Up 0.038
Hydroxysteroid (17-beta) dehydrogenase 4 NM_000414 1.88 Up 0.049
Kv channel interacting protein 2 AF367019 1.52 Up 0.027
Neurogenin 2 AF022859 1.08 up 0.045
Neuron navigator 1 N57538 2.42 Up 0.009
Neuron navigator 2 AA011020 1.11 Up 0.043
Neuropilin 2 AA295257 1.87 Up 0.037
Neuroplastin NM_017455 2.78 Up 0.048
Opioid growth factor receptor AF172449 1.31 Up 0.008
Palmitoyl-protein thioesterase 1 NM_000310 3.04 Up 0.019
PDZ and LIM domain 5 AV715767 5.1 Up 0.006
Peroxisome proliferator-activated receptor delta NM_006238 3.31 Down 0.031
Phytanoyl-CoA 2-hydroxylase NM_006214 2.17 Up 0.049
Potassium channel tetramerisation domain containing 10 AS073741 2.69 Up 0.036
Potassium channel tetramerisation domain containing 15 W73820 1.33 Up 0.013
Potassium voltage-gated channel, delayed-rectifier, subfamily S,
member 3
NM_002252 1.66 Up 0.031
Presenilin 1 NM_007318 1.61 Up 0.024
Regulator of G-protein signaling 5 AF159570 2.31 Up 0.047
Reticulon 4 (Neurite growth inhibitor) AF20999 4.61 Up 0.001
Solute carrier family 38, member 1 NM_030674 2.13 Up 0.039
Solute carrier family 7 (catonic amino acid transporter, y + system),
member 1
AA148507 1.44 Up 0.017
Somatostatin receptor 4 NM_001052 1.09 Down 0.033
S100 calcium binding protein A4 NM_002961 7.44 Up 0.010
Thioredoxin domain containing 12 (endoplasmic reticulum) AF131758 2/42 Up 0.009
Thy-1 cell surface antigen AL161958 3.48 Up 0.006
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Table 3 Significant differences in pain-, neurotrophin-, nerve-, and disc-related genes in more degenerated discs
(Grades iv and v) compared to less degenerated discs (Grades i – iii) (Continued)
B. Proinflammatory cytokine and chemokine genes:
Chemokine (C-X-C motif) receptor 7 AI817041 3.32 Up 0.043
Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) NM_000609 1.90 Up 0.024
FGF receptor 2 T83672 1,12 Up 0.020
IL-17A NM_002190 1.05 Up 0.048
Interferon induced transmembrane protein 1 (9–27) NM_003641 2.72 Up 0.026
PDGF C NM_016205 3.07 Up 0.041
PDGF alpha polypeptide NM_006206 5.73 Up 0.021
PDGF receptor, beta polypeptide NM_003609 2.10 Up 0.033
PDGF receptor-like NM_006207 1.82 Up 0.037
TGF beta NM_000358 6.68 Up 0.035
Latent TGF beta binding protein 1 NM_000627 3.29 Up 0.016
TNF receptor-associated factor 5 NM_004619 1.34 Up 0.014
VEGF B NM_003377 1.09 Up 0.037
C. Genes with special disc relevance:
ADAM metallopeptidase domain 17 NM_003183 1.56 Up 0.001
Apoptosis-inducing factor, mitochondrion associated, 1 NM_004208 1.42 Up 0.019
BMP receptor, type II (serine/threonine kinase) AI457436 1.51 Up 0.027
Calcitonin receptor-like AI1478743 1.51 Up 0.035
Caspase 2, apoptosis-related cysteine peptidase AU153405 1.63 Up 0.028
Caspase 6, apoptosis-related cysteine peptidase BC000305 1.63 Up 0.048
Collagen, type I, alpha 1 K01228 2.69 Up 0.046
Collagen, type I, alpha 2 NM_000089 13.27 Up 0.007
Collagen type III, alpha 1 AU144167 10.3 Up 0.036
Collagen type IV, alpha 2 X05610 2.02 Up 0.021
Collagen type V, alpha 1 AI9833428 1.5 Up 0.039
Collagen type VI, alpha 3 NM_004369 5.85 Up 0.036
Connective tissue growth factor M92934 6.47 Up 0.009
EGF-containing fibulin-like extracellular matrix protein 1 NM_004105 1.49 Up 0.005
Fibronectin 1 AK026737 16.82 Up 0.017
Fibronectin leucine rich transmembrane protein 2 NM_013231 2.78 Up 0.023
Hypoxia inducible factor 1, alpha subunit NM_001530 3.61 Up 0.037
Janus kinase 2 AF001362 1.3 Up 0.002
Laminen, alpha 5 BC003355 1.39 Up 0.042
Laminin, beta 1 NM_002291 2.13 Up 0.045
Lumican NM_002345 17.58 Up 0.015
Mitogen-activated protein kinase 1 AF320999 4.61 Up 0.0017
Mitogen-activated protein kinase 13 BC000433 1.37 Up 0.014
Mitogen-activated protein kinase kinase kinase 3 BF971923 1.67 Up 0.045
Nitric oxide synthase 3 NM_000603 4.77 Down 0.030
SPARC (osteonectin), cwcv and Kazal-like domains proteoglycan
(testican) 1
AF231124 2.74 Up 0.027
Thrombospondin 1 BF055462 1.20 Up 0.033
TIMP metallopeptidase inhibitor 2 BF107565 3.57 Up 0.034
TIMP metallopeptidase inhibitor 3 U67195 2.88 Up 0.035
Vimentin AI520969 1.35 Up 0.031
Gruber et al. Molecular Pain 2012, 8:63 Page 6 of 18
http://www.molecularpain.com/content/8/1/63
Table 4 Significant differences in pain-, neurotrophin-, nerve- and disc related gene expression in surgical compared
to control (CHTN) specimens
Gene name Gene identifier Fold change Direction p-value
A. Pain-, Neurotrophin-, and Nerve-related genes:
Adrenergic, beta, receptor kinase 1 NM_001619 1.28 Down 0.015
Ataxin 1 NM_000332 1.89 Up 0.026
Ataxin 10 AF119662 2.43 Up 0.016
Caireticulin NM_004343 8.53 Up 0.005
Calcitonin gene-related peptide M26095 1.21 Down 0.005
Calcium channel, voltage-dependent, gamma subunit 2 (stargazin) NM_006078 1.18 Down 0.037
Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit AA769818 1.92 Up 0.023
Calcium channel, voltage-dependent, beta 4 subunit NM_000726 1.24 Down 0.001
Calmodulin 3 (phosphorylase kinase, delta) NM_005184 4.29 Up 0.002
Calreticulin NM_004343 8.53 Up 0.005
Cannabinoid receptor 1 (brain) NM_001840 1.14 Down 0.021
Catechol-O-methyltransferase AW139431 1.29 Down 0.035
Chloride intracellular channel 1 L08666 3.61 Up 0.035
Cholinergic receptor, muscarinic 1 AI500293 1.99 Down 0.001
Ciliary neurotrophic factor NM_000614 1.14 Down 0.040
Clusterin AI982754 20.62 Up 0.008
Early growth response 1 NM_001964 5.73 Up 0.013
Family with sequence similarity 123, member B NM_019000 3.45 Up 0.022
Frizzled homolog 8 AB043703 2.81 Up 0.016
G protein-coupled receptor, family C, group 5, member C NM_022036 2.32 Up 0.039
G protein-coupled receptor 87 NM_023915 1.17 Down 0.006
G protein-coupled receptor 98 AF037334 1.17 Down 0.043
G protein regulated inducer of neurite outgrowth 1 AI052709 1.05 Down 0.046
GABA binding protein 2 BC002557 8.78 Down 0.0006
GABA(A) receptor-associated protein NM_007278 4.04 Up 0.038
GABA A receptor, beta 2 NM_021911 1.2 Down 0.006
Gap junction protein, alpha 1, 43 kDa NM_000165 4.1 Up 0.038
Glutamate receptor, ionotropic, delta 2 NM_001510 1.17 Down 0.046
Glutamate receptor, ionotropic, kainite 5 S40369 1.28 Down 0.009
Glutamate receptor, ionotropic, N-methyl D-aspartate 2B NM_024016 1.08 Down 0.017
Glutamate receptor, metabotropic 5 D60132 1.38 Down 0.007
Guanine nucleotide binding protein (G protein), alpha inhibiting activity
polypeptide 3
J03198 2.87 Up 0.040
Guanine nucleotide binding protein (G protein), beta polypeptide 1 NM_002074 4.36 Up 0.009
Guanine nucleotide binding protein (G protein), alpha 11 (Gq class) NM_002067 1.29 Up 0.024
Glutathione peroxidase 1 NM_000581 3.62 Up 0.028
Low density lipoprotein-related protein 1 NM_002332 5.26 Up 0.034
Meteorin, glial cell differentiation regulator BE965311 1.28 Down 0.049
Natriuretic peptide receptor B/guanylate cyclase B NM_003995 1.55 Up J0.033
Nerve growth factor, beta polypeptide NM_002506 1.44 Up 0.03
Netrin 1 BF591483 1.16 Down 0.041
Neugrin, neurite outgrowth associated AL037339 2.66 Up 0.028
Neuroligin 1 AI912122 1.13 Down 0.043
Neuron navigator 1 AB032977 3.83 Up 0.005
Neuro-oncological ventral antigen 1 NM_002515 3.1 Up 0.0008
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Table 4 Significant differences in pain-, neurotrophin-, nerve- and disc related gene expression in surgical compared
to control (CHTN) specimens (Continued)
Neuropilin 2 BC009222 3.28 Up 0.014
Neuroplastin NM_017455 3.61 Up 0.015
Neurotensin NM_006183 1.22 Down 0.009
Nexin (serpin peptidase inhibitor, claude E) AL541302 5.64 Up 0.009
Oligophrenin 1 NM_002547 2.82 Up 0.048
Opioid growth factor receptor-like 1 BE500942 2.4 Up 0.023
Palmitoyl-protein thioesterase 1 NM_000310 3.64 Up 0.005
PDZ and LIM domain 5 AV15767 5.06 Up 0.006
Potassium large conductance calcium-activated channel, subfamily M,
alpha member 1
U11058 3.44 Up 0.040
Potassium voltage-gated channel, shaker-related subfamily, member 10 NM_005549 2.02 Down 0.010
Potassium channel tetramerisation domain containing 20 AV707142 2.34 Up 0.018
Prepronociceptin NM_006228 1.04 Down 0.027
Regulator of G-protein signaling 3 NM_021106 2.45 Up 0.039
Regulator of G-protein signaling 12 AF030111 1.18 Down 0.006
Regulator of G-protein signaling 18 AF076642 1.3 Down 0.025
Reticulon 4 (Neurite growth inhibitor) AB015639 5.96 Up 0.004
Roundabout, axon guidance receptor, homolog 3 NM_022370 1.89 Up 0.025
S100 calcium binding protein A4 NM_002961 12.85 Up 0.003
S100 calcium binding protein A6 NM_014624 6.97 Up 0.013
S100 calcium binding protein B BC001766 3.48 Up 0.009
Sigma non-opioid intracellular receptor 1 NM_005866 1.64 Up 0.031
Solute carrier family 1 (glutamate/neutral amino acid transporter),
member 4
W72527 4.06 Up 0.001
Solute carrier family 29 (nucleoside transporters), member 1 NM_004955 2.89 0.009
Solute carrier family 38, member 1 NM_030674 2.39 Up 0.015
Synaptopodin NM_007286 2.24 Up 0.032
Thioredoxin domain containing 5 (endoplasmic reticulum) NM_030810 6.05 Up 0.002
Thy-1 cell surface antigen AL161958 3.13 Up 0.013
Voltage-dependent anion channel 2 L08666 3.61 Up 0.035
Xylosyltransferase 1 AI693140 6.23 Up 0.004
B. Proinflammatory cytokine and chemokine genes:
Chemokine (C-X-C motif) ligand 2 AV648479 1.15 Down 0.027
Chemokine (C-X-C motif) receptor 7 AI817041 4.13 Up 0.014
FGF 1 (acidic) X59065 2.17 Up 0.033
FGF 5 AB016517 1.47 Down 0.015
FGF receptor substrate 2 AI708648 1.23 Down 0.027
FGF receptor 3 NM_000142 2.62 Up 0.048
FGF receptor substrate 2 AI708648 1.23 Down 0.027
IL-1 receptor-associated kinase 1 NM_001569 3.98 Up 0.010
IL-1 receptor-like 1 NM_003856 1.16 Down 0.041
IL-31 receptor B1 NM_139017 1.17 Down 0.025
IL-6 signal transducer (gp130, oncostatin M receptor) AW242916 1.56 Down 0.032
Interferon gamma receptor 2 NM_005534 2.25 Up 0.041
Macrophate migration inhibitory factor NM_002415 5.71 Up 0.004
PDGF C NM_016205 4.62 Up 0.003
PDGF receptor, alpha polypeptide NM_006206 6.63 Up 0.011
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Table 4 Significant differences in pain-, neurotrophin-, nerve- and disc related gene expression in surgical compared
to control (CHTN) specimens (Continued)
TGF beta NM_000358 8.77 Up 0.014
TGF beta receptor 1 AA604375 3.14 Up 0.023
TNF (ligand) superfamily, member 11 AF053712 3.28 Up 0.009
TNF alpha-indued protein 6 AW188198 9.91 Up 0.006
TNF receptor superfamily member 1A NM_001065 2.01 Up 0.040
TNF receptor superfamily, member 10c, decoy without an
intracellular domain
AK026079 1.34 Down 0.014
TNF receptor superfamily, member 10d, decoy without an
intracellular domain
NM_003841 1.18 Down 0.039
TNF receptor superfamily, member 12A NM_016639 2.01 Up 0.046
TNF receptor superfamily, member 25 U94506 1.16 Down 0.012
TNF receptor-associatee factor 3 AI721219 1.57 Up 0.046
C. Genes with special disc relevance:
ADAM metallopeptidase domain 17 NM_003183 1.38 Up 0.025
ADAM metallopeptidase domain 22 NM_021723 1.18 Down 0.045
BCL2-associated athanogene 5 NM_004873 1.9 Up 0.028
BMP and activin membrane-bound inhibitor homolog NM_012342 3.28 Up 0.008
Brevican AA622130 1.30 Down 0.044
Caspase 6, apoptosis-related cysteine peptidase BC000305 2.05 Up <0.0001
Collagen type II, alpha 1 X)6268 53.83 Up 0.009
EGF-containing fibulin-like extracellular matrix protein 2 NM_005507 11.88 Up 0.012
FGF 5 AB016517 1.47 Down 0.015
Fibronectin 1 AK026737 37.09 Up 0.001
Growth arrest specific 1 NM_002048 5.44 Up 0.006
Growth arrest specific 7 BE439987 2.56 Up 0.040
Heat shock 70kDa protein 5 AW052044 1.34 Up 0.047
Heat shock 70kDa protein 8 AA704004 3.99 Up 0.023
Heat shock protein 90 kDa beta, (group 94), member 1 AK025862 2.45 Up 0.031
Hypoxia inducible factor 1, alpha subunit NM_001530 4.41 Up 0.014
Laminin, beta 2 X79683 3.24 Up 0.029
Latent TGF beta binding protein 1 NM_000627 3.09 Up 0.024
Lumican NM_002345 66.35 Up 0.0001
Lysyl oxidase-like 2 NM_002318 5.06 Up 0.010
Mitogen-activated protein kinase 1 BF434653 1.38 Down 0.018
Mitogen-activated protein kinase 3 X60188 1.94 Up 0.030
Mitogen-activated protein kinase kinase kinase 3 BF971923 1.83 Up 0.016
Mitogen-activated protein kinase 13 BC000433 1.35 Up 0.020
Mitogen-activated protein kinase 14 AA604375 3.14 Up 0.023
Proteoglycan 4 NM_005807 13.72 Up 0.001
PTH 1 receptor NM_000316 1.77 Up 0.047
Retinoic acid receptor, beta NM_000965 1.61 Up 0.036
SOD NM_000454 4.18 Up 0.023
SPARC/osteonectin, cwcv and kazal-like domains proteoglycan
(testican) 1
AF231124 3.00 Up 0.015
Tenascin R Y13359 1.38 Down 0.014
Thyroid stimulating hormone receptor BE045816 1.26 Down 0.019
TIMP metallopeptidase inhibitor 3 NM_000362 12.35 Up 0.001
TIMP metallopeptidase inhibitor 4 NM_003256 2.43 Up 0.042
Versican BF218922 5.19 Up 0.021
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Table 5 Significant differences in pain-, neurotrophin-, nerve-related and disc genes in herniated discs compared to
control (CHTN) discs
Gene name Gene identifier Fold change Direction p-value
A. Pain-, Neurotrophin-, Nerve-related Genes:
Adrenergic, beta, receptor kinase 1 NM-001619 1.33 Down 0.042
Ataxin 1 NM_000332 2.09 Up 0.031
Calcitonin gene related peptide M26095 1.2 Down 0.040
Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit AA769818 2.17 Up 0.018
Calcium channel, voltage-dependent, beta 2 subunit U80764 1.21 Up 0.037
Cannabinoid receptor 1 (brain) NM-001840 1.16 Down 0.029
Chemokine (C-X-C motif) receptor 7 AI817041 4.51 Up 0.012
Cholinergic receptor, muscarinic 1 AI500293 2.05 Down 0.003
Clusterin M25915 20.02 Up 0.003
Corticotropin releasing hormone receptor 1 X72304 1.53 Up 0.035
EPH receptor B3 NM_004443 1.52 Up 0.037
Family with sequence similarity 134, member B NM_019000 3.72 Up 0.021
GABA(A) receptor-associated protein NM_007278 4.39 Up 0.039
GABA A receptor, beta 2 NM_021911 1.21 Down 0.016
G protein-coupled receptor, family C, group 5, member C NM_022036 2.64 Up 0.036
G protein-coupled receptor 52 NM_005684 1.06 Down 0.044
G protein-coupled receptor 161 AI703188 1.71 Up 0.044
G protein signaling modulator 2 (AGS3-like) AW195581 1.94 Up 0.040
Glutamate receptor, metabotropic 5 D60132 1.37 Down 0.026
Glutaminase NM_014905 3.14 Up 0.014
Glutathione peroxidase 1 NM_000581 3.94 Up 0.038
Guanine nucleotide binding protein (G protein), beta polypeptide 1 NM_002074 4.61 Up 0.013
Guanine nucleotide binding protein (G protein), gamma 5 NM_005274 2.62 Up 0.040
Guanine nucleotide binding protein (G protein), gamma 7 AL039870 1.54 Up 0.006
Guanine nucleotide binding protein (G protein), gamma 10 AI765321 1.49 Up 0.040
Guanine nucleotide binding protein (G protein), gamma 11 NM_004126 3.13 Up 0.026
Guanine nucleotide binding protein (G protein), gamma 12 N32508 1.86 Up 0.026
Guanine nucleotide binding protein (G protein), alpha 13 AI928136 2.80 Up 0.022
Kallidrein-related peptidase 8 NM_144506 1.21 Down 0.028
Monoglyceride lipase BG168471 1.79 Up 0.019
Myelin basic protein N37023 3.28 Up 0.003
Natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic
peptide receptor B)
NM_003995 2.14 Up 0.049
Neogenin homolog 1 BF058828 1.28 Down 0.022
Nerve growth factor (beta polypeptide) NM_002506 1.5 Up 0.029
Neural precursor cell expressed, developmentally downregulated 4-like AB007899 1.23 Up 0.038
Neuromedin U receptor 2 AF272363 1.09 Down 0.023
Neuro-oncological ventral antigen 1 NM_002515 3.1 Up 0.001
Neurofibromin 1 M60915 1.04 Up 0.031
Neuromedin U receptor 2 AF272363 1.09 Down 0.023
Neuropilin 2 AA295257 3.92 Up 0.032
Neuroplastin NM_017455 4.46 Up 0.008
Opioid growth factor receptor-like 1 BE500942 2.52 Up 0.017
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Table 5 Significant differences in pain-, neurotrophin-, nerve-related and disc genes in herniated discs compared to
control (CHTN) discs (Continued)
Palmitoyl-protein thioesterase 1 NM_000310 4.34 Up 0.005
Pancreatic polypeptide receptor 1 U42387 1.31 Down 0.048
PDZ and LIM domain 5 AV715767 5.04 Up 0.007
Plexin A1 T16388 1.51 Down 0.046
Potassium voltage-gated channel, shaker-related subfamily, member 10 NM_005549 2.36 Down 0.007
Prostaglandin E receptor 2 (subtype EP2), 53 kDa NM_000956 1.45 Up 0.048
Regulator of G-protein signaling 3 NM_021106 3.15 Up 0.021
Regulator of G-protein signaling 12 AF030111 1.18 Down 0.027
Regulator of G-protein signaling 14 NM_006480 1.13 Up 0.042
Reticulon 4 (neurite growth inhibitor) AB015639 5.58 Up 0.007
Roundabout, axon guidance receptor, homolog 3 NM_022370 1.74 Up 0.048
S100 calcium binding protein A6 NM_014624 9.13 Up 0.017
S100 calcium binding protein A9 NM_002965 1.93 Up 0.046
S100 calcium binding protein B BC001766 4.18 Up 0.012
Sigma non-opioid intracellular receptor NM_005866 2.01 Up 0.022
Solute carrier family 1 (glutamate/neutral amino acid transporter),
member 4
AI889380 2.79 Up 0.013
Solute carrier family 6 (neurotransmitter transporter, creatine), member 8 AI820043 1.65 Down 0.021
Solute carrier family 22, member 17 NM_020372 2.62 Up 0.044
Solute carrier family 29 (nucleoside transporters), member 1 NM_004955 4.03 Up 0.010
Solute carrier family 38, member 1 NM_030674 2.25 Up 0.023
Solute carrier family 38, member 2 NM_018976 2.24 Up 0.048
Solute carrier family 44, member 2 AI264216 1.88 Up 0.020
Syntaxin 1A (brain) NM_004603 2.46 Up 0.017
Syntaxin binding protein 1 NM_003165 1.96 Up 0.049
Thy-1 cell surface antigen NM_000633 2.24 Up 0.025
Xylosyltransferase I AI693140 6.41 Up 0.007
B. Proinflammatory cytokine and chemokine genes:
Chemokine (C-C motif) ligand 22 NM_002990 1.10 Down 0.039
IL 11 receptor, alpha NM_147162 1.03 Down 0.049
IL 17 receptor C BF196320 1.11 Down 0.033
IL 27 receptor, alpha AI983115 1.19 Down 0.042
IL 31 receptor A AF106913 1.33 Down 0.040
IL-1 receptor-associated kinase 1 NM_001569 4.30 Up 0.015
IL-23, alpha subunit P19 AJ296370 1.62 Up 0.023
Interferon gamma receptor 2 NM_005534 2.79 Up 0.028
Latent TGF beta binding protein 1 NM_000627 2.61 Up 0.039
Macrophage migration inhibitory factor NM_002415 5.01 Up 0.034
PDGF receptor, alpha polypeptide NM_006206 5.96 Up 0.018
TGF beta NM_000358 12.34 Up 0.011
TGF beta receptor 1 NM_000714 3.88 Up 0.018
TNF alpha-induced protein 6 AW188198 14.57 Up 0.002
TNF receptor superfamily, member 11b NM_002546 3.31 Up 0.034
TNF receptor superfamily, member 12A NM_016639 2.29 Up 0.042
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Table 5 Significant differences in pain-, neurotrophin-, nerve-related and disc genes in herniated discs compared to
control (CHTN) discs (Continued)
TNF receptor superfamily, member 25 U94506 1.13 Down 0.046
TNF receptor-associated factor 3 AI721219 1.67 Up 0.043
TNF superfamily, member 11 AF053712 4.32 Up 0.002
C. Genes with special relevance to the disc:
ADAM metallopeptidase domain 17 NM_003183 1.36 Up 0.045
BCL2-associated athanogene 5 NM_004873 1.95 Up 0.039
Caspase 6, apoptosis-related cysteine peptidase BC000305 2.48 Up 0.025
Collagen type I, alpha 2 NM_000089 11.05 Up 0.017
Collagen type II, alpha 1 X06268 58.92 Up 0.0001
Collagen type III, alpha 1 AU144167 12.15 Up 0.026
Collagen type VI, alpha 2 AL531750 3.14 Up 0.018
Collagen type VI, alpha 3 NM_004369 8.55 Up 0.013
Collagen type VI, alpha 1 AA292373 3.12 Up 0.037
Collagen type XI, alpha 1 NM_001854 6.45 Up 0.020
Collagen type IX, alpha 3 NM_001853 10.38 Up 0.002
EGF receptor pathway substrate 8 NM_004447 1.55 Up 0.048
EGF-containing fibulin-like extracellular matrix protein 2 NM_005507 9.96 Up 0.037
Fibronectin 1 AK026737 52.43 Up 0.0004
Fibronectin leucine rich transmembrane protein 2 NM_013231 2.61 Up 0.028
Growth arrest-specific 1 NM_002048 5.45 Up 0.006
Growth arrest-specific 7 NM_005890 2.04 Up 0.045
Heat shock 70 kDa protein 8 AA704004 5.36 Up 0.008
Hypoxia indicuble factor 3, alpha subunit NM_001530 4.32 Up 0.027
Hypoxia inducible factor 1 (HIF1A) NM_001530 4.32 Up 0.027
Jun oncogene NM_002228 2.21 Up 0.027
Lumican NM_002345 79.38 Up <0.0001
Lysly oxidase-like 2 NM_002318 5.85 Up 0.009
Mitogen activated protein kinase 1 BF434653 1.44 Down 0.022
Mitogen-activated protein kinase 3 X60188 2.28 Up 0.023
Mitogen-activated protein kinase 8 AU152505 1.41 Up 0.048
Mitogen-activated protein kinase 13 BC000433 1.32 Up 0.030
Mitogen-activated protein kinase 14 NM_001315 4.30 Up 0.006
Never in mitosis gene a (NIMA)-related kinase 8 AI9365173 1.81 Up 0.006
Never in mitosis gene a (NIMA)-related kinase 7 AL080111 2.43 Up 0.039
Proteoglycan 4 NM_005807 18.05 Up 0.001
SOD 1, soluble NM_000454 4.44 Up 0.038
SPARC/osteonectin, cwcv and kazal-like domains proteoclycan
(testican) 1 (SPOCK1)
AF231124 3.3 Up 0.010
Thyrotropin-releasing hormone receptor D16845 1.25 Down 0.004
TIMP metallopeptidase inhibitor 2 BF107565 2.9 Up 0.046
TIMP metallopeptidase inhibitor 3 NM_000358 15.36 Up 0.002
Versican BF218922 6.59 Up 0.013
Vitamin D receptor AA454701 1.19 Down 0.039
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peptide, catechol-0-methyltransferase and bradykinin re-
ceptor B1). For each of these immunolocalizations, cells
were present with localization in single cells, clusters of
cells, and both rounded and spindle-shaped cells in the
outermost region of the annulus. Representative images
are shown in Figures 1A-C; Figure 1D presents a nega-
tive control with the absence of any localization. Note
that in Figures 1A-C adjacent cells were occasionally
present which showed no localization.Discussion
In the present study we performed a genome-wide
microarray analysis of human annulus tissue from
patients with discogenic back pain compared to disc tis-
sue from control subjects or compared to and herniated
disc patients we had a special focus upon analysis of the
expression of pain, nerve and neurotrophin-related
genes. Ontology searches were an efficient search tech-
nique for identification of pain, and nerve-related genes
[14]. Although there is a large body of clinical literature
on low back pain, molecular studies are few, and those
in the literature primarily focus upon population-based
genetic studies of polymorphisms (SNPs) (see [13] for a
review of pain and spinal disease). To the best of our
knowledge, the present work is the first (non-SNP)
genome-wide study of pain, neurotrophin and nerve-
related genes in disc degeneration.Figure 1 Immunohistochemical localizations of calcitonin
gene-related peptide, catechol-0-methyltransferase and
bradykinin receptor B1: Representative images showing
localization of calcitonin gene-related peptide (Figure 1A), catechol-
0-methyltransferase (Figure 1B) and bradykinin receptor B1 (Figure
1C) in annulus regions of the human disc. Figure 1D illustrates a
negative control. Arrows mark nearby cells which did not show
localization.Pain-related genes
Several well-recognized pain-related genes were found
to have significant elevations in our analyses. Bradykinin
receptor B1, calcitonin gene-related peptide and
catechol-0-methyltransferase were significantly elevated
in more degenerated discs (grade IV and V) compared
to less degenerated (grades I-III) discs (Table 1). Brady-
kinin receptor B1 is formed after tissue injury and med-
iates hyperalgesia in chronic inflammation, but has very
low expression in healthy tissue expression [16]. Calci-
tonin gene-related peptide (CGRP) has been found to be
elevated in sensory nerves innervating inflamed tissue
[17], in dorsal root ganglia and spinal cord in sciatic
nerve injuries in the rat model by Orita et al. [18]. In the
latter work, application or antibodies to nerve growth
factor or its receptors TrkA or p75NTR blocked CGRP
expression. Catechol-0-methyltransferase (COMT) codes
for a protein which is important in catabolic pathways of
a number of pain-relevant neurotransmitters, including
noradrenalin, adrenaline and dopamine [19]. In the
present analyses comparing surgically operated discs to
control discs (Table 4) and herniated to control discs,
calcitonin gene-related peptide was the only one of these
genes which was significant, and in these comparisons it
was downregulated 1.2-fold. The COMT gene is very
interesting since patients with a specific polymorphism
identified by Zubieta et al. showed higher sensory and
affective pain ratings [20].
Our ability to perform immunolocalization studies on
human annulus tissues to determine the presence of brady-
kinin receptor B1, calcitonin gene-related peptide and
catechol-0-methyltransferase (Figure 1) added strength to
the present study, and confirmed the presence of products
of these gene at the protein level within human disc tissue.
Neurotrophin-related genes
Neurotrophins were also identified in the present ana-
lyses, including nerve growth factor in our studies of
surgical vs. control discs, and herniated vs. control discs
(significantly upregulated, Tables 4 and 5, respectively),
and ciliary neurotrophic factor (down regulated, Table 4,
surgical vs. control discs).
Studies have recently shown production of several
neurotrophins by disc cells. Gigante et al. reported
the presence of nerve growth factor (NGF) mRNA
and the high affinity tyrosine kinase A receptor (trkA)
and the low affinity p75 receptor in the rounded cells
in the disc annulus and nucleus pulposus [21]. Re-
cently Abe et al. reported on the expression of nerve
growth factor (NGF) by human disc cells in control
disc tissue in vivo and in vitro in cells from control
discs using immunocytochemistry [22]. Nerve growth
factor was found to be high in the outer annulus and
herniated disc tissue. That work also demonstrated
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alpha had stimulatory effects on NGF. These authors
suggested that such actions may play a role in nerve
sprouting into the disc and may be associated with
discogenic pain. Recent in vitro work from our lab
has also confirmed that exposure of disc cells to IL-
1ß in three-dimensional culture (which more accur-
ately mimics the in vivo condition) results in elevated
production of nerve growth factor by human annulus
cells [23].
Ciliary neurotrophic factor whose expression is
reported here, has not previously been known to be
expressed in the human disc. Work from previous stud-
ies has shown that it can act as both a neuroprotective
agent [24] and a trophic factor for motor neurons [25].
Nerve-related genes
Several nerve-related genes should be mentioned in our
analyses, including neuron navigator-1 and −2, neuropi-
lin 2, reticulon 4 (neurite growth inhibitor), roundabout
axon guidance receptor, homolog 3, and neural pre-
cursor cell expressed (developmentally down regulated
4-like) (Tables 3, 4 and 5). These genes also have
not previously been known to be expressed in the
human disc.
Neuron navigator 1 is a microtubule-associated pro-
tein involved in neuronal migration [26], and neuron
navigator 2 is required for all-trans retinoic acid-
mediated neurite outgrowth and axonal elongation [27].
Neuropilin 2 was significantly upregulated in all of our
disc comparisons (Tables 3, 4 and 5). Neuropilin 2 is an-
other gene which we have found to be significantly upre-
gulated in cultured annulus cells exposed to IL-1ß [23].
Neuropilin-1 and neuropilin-2 are membrane proteins
implicated in aspects of neurodevelopment. They are
semaphorin III receptors as shown by the work of Kolod-
kin et al. [28], and are expressed in overlapping popula-
tions of neurons in the embryonic nervous system.
Semaphorin III is a protein which, when secreted in vitro,
results in the collapse of neuronal growth cones and
chemorepulsion of neurites. It is also needed for correct
sensory afferent innervation [29]. Expression of this gene
by annulus cells may provide evidence that annulus cells
express this gene to block neurite ingrowth into the disc.
Roundabout (ROBO1) is a gene which encodes a
receptor which is a member of the neural cell adhesion
molecule family. It functions as an axon guidance recep-
tor [30]. We found upregulation of this gene in surgical
vs. control specimens (Table 4) and in herniated vs.
control specimens (Table 5).
Reticulon 4 (neurite growth inhibitor) was identified
with upregulation in each of our analyses, with 4.6 fold
(Table 3, more degenerated discs vs. less degenerated
discs), 5.96 fold (Table 4, surgical vs. control discs) and5.58 fold (Table 5, herniated vs. control discs) changes.
This gene, also called NOGO, is a neurite outgrowth
inhibitor [31].Genes related to proinflammatory cytokines
and chemokines
In Tables 3, 4 and 5, in the section headed “Genes with
special disc relevance” we have listed many proinflam-
matory cytokines and chemokines identified in our
analyses. These deserve special mention here because a
large number of proinflammatory cytokines are well
recognized as products of disc cells themselves in vivo
(see [32-36] for an introduction to this field). Many
chemokines are also produced by disc cells (our unpub-
lished data). It is very important to note in the present
study that many proinflammatory cytokines and chemo-
kines are now known to induce or exacerbate inflamma-
tory and neuropathic pain and hyperalgesia [37-39]. We
suggest here that this is an exceptionally important
aspect of low back pain that has here-to-fore been little
recognized. The degenerating human disc is primarily an
avascular tissue site into which disc cells have contribu-
ted high levels of proinflammatory cytokines which are
not cleared from the tissue and remain there over time.
We suggest that as nerves grow into the human annulus,
they encounter a proinflammatory cytokine-rich milieu
which exacerbates pain production.
Kim et al. using in vitro work has suggested that disc
cells themselves are involved in inflammatory activities,
and suggested that interactions between annulus cells
and nerve cells enhances the production of growth fac-
tors responsible for neovascularization and nerve in-
growth into the disc [40]. Previous research by Aoki
et al. showed that disc inflammation potentially pro-
moted axonal regeneration of dorsal root ganglion neu-
rons innervating the disc in a rat model [41]. Using
gene correlations, recent work by Lee et al. suggests that
IL-1ß is generated during degeneration of the disc, and
this stimulates expression of agents such as nerve growth
factor, which result in nerve in growth into the disc [42].
It is important to recognize that proinflammatory
cytokine production within the degenerating disc can
also be exacerbated by repeated disc injury, which may
lead to persistent proinflammatory cytokine elevation
[43]; thus repeated disc injury may also influence neu-
roinflammation and pain.
A final important comment from the joint literature
on proinflammatory mediators concerns the fact that re-
lease of these agents in damaged tissue and in the spinal
cord is known to sensitize the peripheral terminals
of nociceptors [44]. It is possible that similar hyper
excitability of pain transmitting neurons results from
proinflammatory cytokines in the disc matrix during
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play here are IL-1ß and TNF-α.
Genes which share high importance to the disc itself
It was interesting that many genes were identified in our
analyses which have relevance to the nerve, neurotro-
phin and pain ontology and to disc biology itself (as
shown in section C of Tables 3, 4 and 5). These included
extracellular matrix (ECM) components, such as col-
lagens, fibronectin, laminin, thrombospondin, brevican,
proteoglycans, and versican, and also genes related to
matrix degradation (metallopepdiases and TIMP metal-
lopeptidase inhibitors), growth factors (connective tissue
growth factor), nitric oxide synthase 3 (ENOS), SOD,
and hypoxia inducible factor 1 alpha subunit. Also
important to disc biology were the vitamin D receptor
gene, growth arrest specific genes (important to cell sen-
escence), apoptosis-related genes, and BMP receptor
type II. Although some of these gene products may be
resident only in sites of neurovascular ingrowth, many
may influence the disc ECM itself and disc cell func-
tions. Such findings point to the importance of future
research directed towards identifying functional interac-
tions between disc and nerve cells in vivo and in vitro.
For example, it has long been recognized that there is
an accumulation of fibronectin fragments in the aging/
degenerating disc, and these fragments initiate signaling
pathways which can increase MMP expression causing a
cycle of matrix destruction [45-50]. Strong up regulation
of fibronectin was present in our analyses (16.8 fold
upregulation in more degenerated vs. healthier discs
(Table 3), 37.0 fold upregulation in surgical vs. control
discs (Table 4), and a 52.4 fold up regulation in her-
niated vs. control discs (Table 5).
Possible limitations to the present analyses include the
fact that some specimens, noted as “controls” in Table 1,
were obtained from the Cooperative Human Tissue Net-
work (CHTN). Although these were shipped quickly to
our lab post-autopsy as quickly as possible via CHTN,
delays might result in potential alterations in mRNA
levels during our study. The reader should note that in
order to carefully investigate this issue, in Table 4 we
compared findings in surgical specimens vs. those
obtained from CHTN. As would be expected in different
sized microarray group comparisons with ontology
searchers, Table 4 does differ in some respects from data
presented in Table 3. It is also worth noting that in our
laboratory, CHTN specimens are also routinely used for
derivation of disc cells in vitro, and in our hands over
98% of CHTN specimens yielded viable cells.
Another point for the reader to note is that our tables
have reported gene expression fold changes which in
some cases were less than 2.0, a level which is com-
monly used. Since we feel that smaller changes inimportant genes may be clinically relevant, we have
reported these changes in our data tables.Conclusions
Even though our three study groups were not large, the
present analysis showed that microarray analysis could
successfully be used to examine key pain-, neurotrophin-
and nerve-related genes in specimens of human disc tis-
sue. Many genes were found in these ontology searches
which held significance not only for nerves, pain and
neurotrophins, but also for disc ECM, signaling and
functional components. Key findings included confirm-
ation of the presence of calcitonin gene-related peptide,
catechol-0-methyltransferase and bradykinin receptor B1
at the protein level in the human annulus using immu-
nohistochemistry, and identification of significant changes
in a number of proinflammatory and chemokine genes
identified from nerve, neurotrophin and pain ontology
searches. Since the disc is primarily avascular, and since
disc cells themselves produce proinflammatory cytokines
and chemokines which are not removed from the tissue,
we hypothesize that as nerves grow into the human annu-
lus, they encounter a proinflammatory cytokine-rich mi-
lieu which may sensitize nociceptors and exacerbate pain
production. Findings reported here point to the import-
ance of future studies of the functional interactions be-
tween disc and nerve cells in vivo and in vitro.Methods
Clinical study population
Experimental study of human disc specimens was
approved prospectively by the authors’ Human Subjects
Institutional Review Board. The need for informed con-
sent was waived by the ethical board since disc tissue
was removed as part of routine surgical practice. Scoring
of disc degeneration utilized a modification of the
Thompson scoring system [51] incorporating author
ENH’s radiologic, MRI and surgical findings. The
Thompson system scores disc degeneration over the
spectrum from a healthy disc (Thompson grade I) to
discs with advanced degeneration (grade V, the most
advanced stage of degeneration) [51]. Patient specimens
were derived from surgical disc procedures performed
on individuals with herniated discs and degenerative disc
disease. Surgical specimens were transported to the
laboratory in sterile tissue culture medium. Non-surgical,
control donor disc specimens were obtained via the
National Cancer Institute Cooperative Human Tissue
Network (CHTN); they were shipped overnight to the
laboratory in sterile tissue culture medium and processed
as described below. Specimen procurement from the
CHTN was included in our approved protocol by our
human subjects Institutional Review Board.
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Disc tissue was snap frozen in liquid nitrogen, pul-
verized (BioPulverizer, BioSpec Products, Inc., Bar-
tlesville, OK, USA), and homogenized via the
FastPrep-24 instrument (MP Biomedicals L.L.C.,
Santa Ana, CA, USA). Total RNA was isolated via a
modified version of TRIzol Reagent (Life Technolo-
gies: Invitrogen, Carlsbad, CA, USA), and prepared
for microarray hybridization using the GeneChip 3’
IVT Express Kit (Affymetrix, Santa Clara, CA). In
brief, total RNA was reverse transcribed to
synthesize cDNA, converted to double stranded
DNA, subjected to transcription generating biotin-
labeled amplified RNA (cRNA) and hybridized to the
DNA microarray in the Affymetrix Fluidics Station
400. Affymetrix human U133 X3P arrays were used.
The GCOS Affymetrix GeneChip Operating System
(version 1.2, Affymetrix, Santa Clara, CA 95051) was
used for determining gene expression levels. mRNA
from annulus tissue from each subject was analyzed
separately (i.e., samples were not pooled).Statistical analysis
The GCOS Affymetrix GeneChip Operating System
(version 1.2, Affymetrix, Santa Clara, CA) was used
for determining gene expression levels. GeneSifterTM
web-based software (VizX Labs, Seattle, WA, USA)
was used to analyze all microarray data. Using GC-
RMA (Robust multi-array average), Affymetrix ‘.cel’
files were uploaded to the GeneSifterTM web site and
normalized, and corrected for false discovery rate
(FDR). Using the student t-test (2 tailed, unpaired),
statistical significance was determined (p < 0.05).
Gene Ontology (GO) searches were employed in
our analyses to select genes of interest and groups
of critically important genes. This approach lets one
avoid searching through results gene by gene, and
provides a controlled vocabulary of search terms for
gene characteristics. In our analyses, Gene Ontolo-
gies (GO) were generated by GeneSifterTM based on
the Gene Ontology Consortium. Searches were per-
formed in the present study on “pain” and “nerve”;
for each, ontologies were searched under “biological
process”, “molecular function” (the activities of the
gene product at the molecular level), and “cellular
component” (parts or cells or the extracellular mi-
lieu). To aid the reader in visualizing the key terms
covered in these ontology grouping, details are pro-
vided in Table 2.
Gene array data for the human disc specimens anal-
yzed here have been uploaded to the Gene Expression
Omnibus (GEO) website [GEO:GSE23130] and may be
accessed there.Immunohistochemistry
Bradykinin receptor B1 (BDKRB1) and calcitonin gene
related peptide (CGRP) Immunohistochemistry: Disc
specimens were fixed in 10% neutral buffered formalin,
embedded undecalcified, paraffin sections cut at 4 μm,
collected on PLUS slides(Cardinal Health, Dublin, OH)
and dried at 60°C. Sections were deparaffinized in xylene
(Cardinal) and rehydrated through graded alcohols
(AAPER, Shelbyville, KY) to distilled water. Antigen
retrieval was performed using Biocare Antigen Decloa-
ker Solution, pH 6.0 (Biocare Medical, Concord, CA) for
20 minutes at 95°C followed by cooling for 20 minutes.
The remainder of the procedure was performed using
the Dako Autostainer Plus (Dako, Carpenteria, CA)
automated stainer. Endogenous peroxidase was blocked
using 3% H202 (Sigma, St Louis, MO). Slides were incu-
bated for 30 minutes with Serum-Free Protein Block
(Dako); blocking solution was drained from slides and
primary antibody applied. Sections were incubated for
one hour with anti-Bradykinin receptor B1 (BDKRB1)
(Novus Biologicals, Littleton, CO) at a 1:50 dilution, or
with for one hour with anti-calcitonin gene related pep-
tide (CGRP) (Abcam, Cambridge, MA) at a 1:100 dilu-
tion. Secondary antibody was 4 + Biotinylated Universal
Goat Link (Biocare) for 10 minutes followed by 4+ strep-
tavidin HRP Label (Biocare) for 10 minutes and DAB
(Dako) for 5 minutes. Slides were removed from stainer,
rinsed in water, counterstained with light green, dehy-
drated, cleared and mounted with resinous mounting
media. Universal Rabbit Negative (Dako, Carpinteria,
CA) was used as a negative control.
Catechol-O-methyltransferase (COMT) immunohisto-
chemistry did not require antigen retrieval. Sections were
prepared as described above, and incubated for one hour
with anti-catechol-O-methyltransferase (COMT) (Life-
span Biosciences, Seattle, WA) at a 1:200 dilution. The
secondary antibody and negative control utilized were as
described above.
Positive control human tissues were also included with
each immunolocalization run; for bradykinin receptor B1
this was brain, for calcitonin gene related peptide this was
thyroid, and for catechol-O-methyltransferase, adrenal.
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